Diadenosine polyphosphates in tears of sjögren syndrome patients

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 11, 2010, Pages 5452-5459

  Carracedo, Gonzalo ^a   Peral, Assumpta ^a   Pintor, Jesús ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIADENOSINE PENTAPHOSPHATE; DIADENOSINE POLYPHOSPHATE; DIADENOSINE TETRAPHOSPHATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRY EYE; DRY EYE QUESTIONNAIRE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LACRIMATION; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHIRMER TEST; SJOEGREN SYNDROME;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINUCLEOSIDE PHOSPHATES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SJOGREN'S SYNDROME; TEARS;

EID: 79451475749     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-5088     Document Type: Article

References (27)

1. Srinivasan S, Slomovic AR. Sjogren syndrome. Compr Ophthalmol Update. 2007;8(4):205-212.
2. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554-558.
3. Pillemer SR, Matteson EL, Jacobsson LT, et al. Incidence of physician- diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001;76(6):593-599.
4. Garcia-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270-280.
5. Vescovi P, Manfredi M, Cimarosti S. Sjogren's syndrome: clinical and therapeutic features: a review of the literature (in Italian). Minerva Stomatol. 2004;53(1-2):1-19.
6. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Work Shop. Ocul Surf. 2007;5(2):108-152.
7. Pintor J, Carracedo G, Alonso MC, Bautista A, Peral A. Presence of diadenosine polyphosphates in human tears. Pflugers Arch. 2002; 443(3):432-436.
8. McLennan AG. Dinucleoside polyphosphates: friend or foe? Pharmacol Ther. 2000;87(2-3):73-89.
9. Peral A, Carracedo G, Acosta MC, Gallar J, Pintor J. Increased levels of diadenosine polyphosphates in dry eye. Invest Ophthalmol Vis Sci. 2006;47(9):4053-4058.
10. Pintor J, Peral A, Hoyle CH, et al. Effects of diadenosine polyphosphates on tear secretion in New Zealand white rabbits. J Pharmacol Exp Ther. 2002;300(1):291-297.
11. Pintor J, Bautista A, Carracedo G, Peral A. UTP and diadenosine tetraphosphate accelerate wound healing in the rabbit cornea. Ophthalmic Physiol Opt. 2004;24(3):186-193.
12. Pintor J, Peral A, Pelaez T, Martin S, Hoyle CH. Presence of diadenosine polyphosphates in the aqueous humor: their effect on intraocular pressure. J Pharmacol Exp Ther. 2003;304(1):342-348.
13. Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20(6):610-618.
14. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82(1):10-14.
15. Pintor J, Torres M, Miras-Portugal MT. Carbachol induced release of diadenosine polyphosphates-Ap4A and Ap5A-from perfused bovine adrenal medulla and isolated chromaffin cells. Life Sci. 1991;48(24):2317-2324.
16. Pintor J, Diaz-Rey MA, Torres M, Miras-Portugal MT. Presence of diadenosine polyphosphates-Ap4A and Ap5A-in rat brain synaptic terminals: Ca2μ dependent release evoked by 4-aminopyridine and veratridine. Neurosci Lett. 1992;136(2):141-144.
17. Acosta MC, Peral A, Luna C, Pintor J, Belmonte C, Gallar J. Tear secretion induced by selective stimulation of corneal and conjunc- tival sensory nerve fibers. Invest Ophthalmol Vis Sci. 2004;45(7): 2333-2336.
18. Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44(11):4753-4761.
19. Barboza MN, Barboza GN, de Melo GM, et al. Correlation between signals and symptoms of dry eye in Sjogren's syndrome patients (in Portuguese). Arq Bras Oftalmol. 2008;71(4):547-552.
20. Tsubota K, Hata S, Okusawa Y, Egami F, Ohtsuki T, Nakamori K. Quantitative videographic analysis of blinking in normal subjects and patients with dry eye. Arch Ophthalmol. 1996;114(6):715-720.
21. Cowlen MS, Zhang VZ, Warnock L, Moyer CF, Peterson WM, Yerxa BR. Localization of ocular P2Y2 receptor gene expression by in situ hybridization. Exp Eye Res. 2003;77(1):77-84.
22. Yerxa BR, Mundasad M, Sylvester RN, Garden JC, Cooper M, Kellerman DJ. Ocular safety of INS365 ophthalmic solution, a P2Y2 agonist, in patients with mild to moderate dry eye disease. Adv Exp Med Biol. 2002;506:1251-1257.
23. Turner JT, Landon LA, Gibbons SJ, Talamo BR. Salivary gland P2 nucleotide receptors. Crit Rev Oral Biol Med. 1999;10(2):210-224.
24. Schrader AM, Camden JM, Weisman GA. P2Y2 nucleotide receptor upregulation in submandibular gland cells from the NOD.B10 mouse model of Sjogren's syndrome. Arch Oral Biol. 2005;50(6): 533-540.
25. Baker OJ, Camden JM, Rome DE, Seye CI, Weisman GA. P2Y2 nucleotide receptor activation upregulates vascular cell adhesion molecule-1 [corrected] expression and enhances lymphocyte adherence to a human submandibular gland cell line. Mol Immunol. 2008;45(1):65-75.
26. Farris RL, Stuchell RN, Mandel ID. Basal and reflex human tear analysis. I. Physical measurements: osmolarity, basal volumes, and reflex flow rate. Ophthalmology. 1981;88(8):852-857.
27. Versura P, Cellini M, Torreggiani A, Profazio V, Bernabini B, Caramazza R. Dryness symptoms, diagnostic protocol and therapeutic management: a report on 1,200 patients. Ophthalmic Res. 2001; 33(4):221-227.